The most important financial indicators for the company Qar Clinical Research Srl - Unique Identification Number 29659752:
sales in 2023 was
25.978
euro, registering a net profit of
1.399
euro and having an average number of
1
employees.
Firma isi desfasoara activitatea in domeniul Activitati de asistenta medicala specializata having the NACE code 8622.
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity. The data show the company's evolution during this period, highlighting any increases or potential decreases recorded.
In the last year of activity, the sales increased by 48.7%, from 17.521 euro in the year 2022, to 25.978 euro in 2023.
The Net Profit decreased by -16.215 euro, from 17.668 euro in 2022, to 1.399 in the last year.
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Qar Clinical Research Srl - CUI 29659752
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Fixed Assets
183
185
183
1.765
1.527
1.498
1.469
1.531
51.321
40.265
Current Assets
42.450
10.771
8.433
24.241
25.482
23.101
12.996
10.886
12.122
7.643
Inventories
593
0
0
0
0
0
0
0
0
0
Receivables
24.418
10.551
71
7.066
4.386
120
97
186
7.502
10
Cash
17.438
220
8.362
17.175
21.096
22.981
12.898
10.700
4.621
7.633
Shareholders Funds
42.350
10.409
6.513
24.080
23.867
22.857
12.030
8.733
17.716
11.482
Social Capital
45
45
45
44
43
42
41
40
41
40
Debts
283
547
2.103
1.926
3.142
1.742
2.435
5.823
45.727
36.427
Income in Advance
0
0
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
4.4821
Main CAEN
"8622 - 8622"
CAEN Financial Year
8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
7.643 euro in 2023 which includes Inventories of
0 euro, Receivables of
10 euro and cash availability of
7.633 euro.
The company's Equity was valued at
11.482 euro, while total Liabilities amounted to
36.427 euro.
Equity decreased by -6.181 euro, from 17.716 euro in 2022, to 11.482 in 2023.
Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Qar Clinical Research Srl